Clinical trial reportCancer chemotherapy and pharmacologyPublished
Phase 1 study of the pan-RAF inhibitor tovorafenib in patients with advanced solid tumors followed by dose expansion in patients with metastatic melanoma
Regional connection
Verified Author affiliations on the Europe PMC record name Fox Chase Cancer Center, Temple University, with Temple Health linked by the institution reference. Affiliation source
- Institutions
- Fox Chase Cancer Center, Temple Health, Temple University
- County
- Philadelphia County
Publication record
- Type
- Clinical trial report
- Venue
- Cancer chemotherapy and pharmacology
- Published
- Topic
- Clinical care
- Subject terms
- Humans; Neoplasms; Melanoma; Skin Neoplasms; Neoplasms, Second Primary; Proto-Oncogene Proteins B-raf; Mitogen-Activated Protein Kinase Kinases; Protein Kinase Inhibitors; Maximum Tolerated Dose; Adult; Braf; Phase 1
- PubMed ID
- 37219686
- PubMed Central ID
- PMC10261210
- Open access
- Yes, open
- Added to directory
- Source checked